AVITA Medical operates as an independent, publicly traded commercial-stage medical technology enterprise listed on the NASDAQ and the Australian Securities Exchange, rather than being a subsidiary of a larger healthcare conglomerate. It collaborates extensively with major hospital networks, premier burn centers, academic medical institutions, and group purchasing organizations worldwide to distribute its proprietary regenerative tissue-restoration products directly to clinical practitioners and surgical teams.